Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
06/2005
06/23/2005US20050137242 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments
06/23/2005US20050137234 Histone deacetylase inhibitors
06/23/2005US20050137232 Histone deacetylase inhibitors
06/23/2005US20050137168 inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor; for treatment and/or prevention of arterial and venous thrombosis, deep vein thrombosis, pulmonary embolism, unstable angina pectoris, cardiac infarction, stroke
06/23/2005US20050136014 esters with with C16 to C50 alcohols and/or siloxane derivatives; increased water resistance, increased stability, improved permanence
06/23/2005CA2548262A1 Method for the production of tetrahydrogeranylacetone
06/23/2005CA2547391A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
06/22/2005EP1542678A1 1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE DERIVATIVES AS CANNABINOID-CB sb 1 /sb RECEPTOR LIGANDS
06/22/2005EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases
06/22/2005EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme
06/22/2005EP1047672B1 Process for preparing sparingly soluble aromatic amines
06/22/2005CN1630632A Aromatic amino acid derivates and medicinal compositions
06/22/2005CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use
06/22/2005CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound
06/22/2005CN1207287C Ester compounds of bezimidazole and their preparations and uses in preparation of medicinal compound
06/22/2005CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
06/21/2005US6908948 Saturated nitrogen compounds, that bind to nucleic acids and generate chemical intermediates that splice the strands; prophylaxis of tumors and viral diseases
06/21/2005US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005US6908926 Substituted imidazoles, their preparation and use
06/16/2005WO2005053631A1 Microcapsules with uv filter activity and process for producing them
06/16/2005WO2005003081A3 Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells
06/16/2005US20050131039 Benzimidazole derivatives, their production and use
06/16/2005US20050131018 Acetylene derivatives as inhibitors of histone deacetylase
06/16/2005US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
06/16/2005US20050130966 Sodium channel modulators
06/16/2005CA2547791A1 Therapeutics use of pyridinium compounds to modulate naadp activity
06/16/2005CA2546117A1 1h-imidazoquinoline derivatives as protein kinase inhibitors
06/16/2005CA2541691A1 1h-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases
06/15/2005EP1541146A1 Zolpidem hemitartrate solvate
06/15/2005EP1539740A1 Sulphonamide derivatives and their use as tace inhibitors
06/15/2005EP1539708A1 Benzimidazolones and their use as cytokine inhibitors
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP1173407B1 Method for nitrating aniline derivatives
06/15/2005EP1020451B1 Anilide compounds and drugs containing the same
06/15/2005EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
06/15/2005CN1628112A Polymorph of acid 4-[2-[4-[1-2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piper idinyl]ethyl]-dollar G (A), dollar G (A)-dimethyl-benzeneacetic
06/14/2005US6906078 Method of using (H+/K+) ATPase inhibitors as antiviral agents
06/14/2005US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH
06/14/2005US6906072 Central nervous system disorders
06/09/2005WO2005051901A1 Anti-cancer agents
06/09/2005WO2005051317A2 Substituted imidazo ring systems and methods
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
06/09/2005US20050124638 Benzimidazoles and analogs thereof as antivirals
06/09/2005US20050123795 Having a phosphorescent light emitting layer containing an organometallic complex with Iridium, Rhodium, Osmium, Platinumt, or Palladium and a fused pyrazole or imidazole compound
06/09/2005CA2547020A1 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
06/08/2005EP1537110A2 Triazospiro compounds having nociceptin receptor affinity
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1019045B1 Antithrombotic agents
06/08/2005CN1625552A New material for transporting electrons and organic electroluminescent display using the same
06/08/2005CN1623988A Biaryl sulfonamides and methods for using same
06/08/2005CN1623984A Fused-ring compounds and use thereof as drugs
06/08/2005CN1623537A Biaryl sulfonamides and its using method
06/08/2005CN1205213C Method for the production of imidazol-[1,2-c][2,3]-benzodiazepines and intermediates in production thereof
06/08/2005CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
06/07/2005US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/07/2005US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
06/07/2005US6903126 1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
06/07/2005US6903094 As analgesic
06/02/2005WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
06/02/2005WO2005028445A3 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
06/02/2005US20050119319 Using 1,3-diazaspiro( 4.5)decane-2,4-(dione or dithione)
06/02/2005US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release
06/02/2005US20050119256 Aromatic amino acid derivates and medicinal compositions
06/02/2005US20050119236 Cancer treatments and pharmaceutical compositions therefor
06/02/2005US20050116626 Iridium complexes as light emitting materials and organic light emitting diode device
06/02/2005DE10335545A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
06/02/2005CA2545484A1 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
06/01/2005EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
06/01/2005EP1534273A2 Modulators of the glucocorticoid receptor and method
06/01/2005EP1178977B1 Ion channel modulating agents
06/01/2005EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
06/01/2005CN1204144C Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
06/01/2005CN1204125C New synthesis route of candixatan ester
06/01/2005CN1204124C New preparation method of timixatan
05/2005
05/31/2005US6900235 Anticancer agents; viricides
05/31/2005US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents
05/31/2005US6899739 Hair dyes
05/26/2005WO2005047266A1 Aryl imidazoles and their use as anti-cancer agents
05/26/2005WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005WO2004108686A3 Benzimidazole compounds having hypoglycemic activity
05/26/2005US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid
05/26/2005US20050113440 Compounds that modulate PPAR activity and methods for their preparation
05/26/2005US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
05/26/2005US20050113362 Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
05/26/2005US20050112407 Organic electroluminescent device
05/26/2005CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists
05/25/2005EP1532119A2 Aryl substituted benzimidazoles and their use as sodium channel blockers
05/25/2005EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
05/25/2005EP1531674A2 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
05/25/2005EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2005CN1620437A Method for the production and purification of 1, 7'-dimethyl-2'-propyl-2, 5'-bi-1h-benzimidazole
05/25/2005CN1620423A Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR)
05/25/2005CN1620422A Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR)
05/25/2005CN1618926A Organic electroluminescent material, organic electroluminescent device and hetrocycle-containing iridium complex compound
05/19/2005WO2005044807A2 Benzoimidazole compounds
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 154